» Articles » PMID: 29335806

Assessment of Ocular Toxoplasmosis Patients Reported at a Tertiary Center in the Northeast of Iran

Overview
Journal Int Ophthalmol
Specialty Ophthalmology
Date 2018 Jan 17
PMID 29335806
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Ocular toxoplasmosis, which is caused by the single-cell parasite Toxoplasma gondii, is currently the most significant cause of posterior uveitis in the world. No previous studies have described the prevalence and clinical features of ocular toxoplasmosis in the northeast of Iran. The purpose of the current study was to address this gap.

Methods: In this retrospective study, the medical records of 488 uveitis patients who presented to the Khatam-al-Anbia Eye Hospital of Mashhad University of Medical Sciences, a tertiary ophthalmology center in the northeast of Iran, between January 2013 and December 2015 were evaluated. The clinical features and risk factors of 99 (20%) consecutive patients with ocular toxoplasmosis were extracted.

Results: Ninety-nine including 53 (53.5%) female and 46 (46.5%) male patients with ocular toxoplasmosis were included in the analysis. Reduced vision (77%) and floaters (15.2%) were the most common presenting symptoms. The age category that was most affected by ocular toxoplasmosis was 20-40 years (range: 11-65 years) with a mean age of 27.2. All patients had retinochoroiditis, but just two had anterior uveitis. All of the extracted patients, with the exception of three patients, had unilateral involvement. None of the patients had any other medical disorders with the exception of one woman, who had diabetes. Only four recurring ocular toxoplasmosis patients were referred to the education hospital during the study. Serology data were available for just 32 patients, of which 31 (96.8%) were IgG positive, and 1 (3.2%) was IgM positive.

Conclusion: Toxoplasma gondii was responsible for 20% of the patients of uveitis that presented to the largest ophthalmology center in the northeast of Iran. There is a high incidence of patients of ocular toxoplasmosis in the northeast of Iran, and it is a significant cause of uveitis and visual impairment in this area.

Citing Articles

Fuchs' uveitis syndrome: a 20-year experience in 466 patients.

Kianersi F, Kianersi H, Pourazizi M, Beni A, Noorshargh P Sci Rep. 2024; 14(1):8621.

PMID: 38616214 PMC: 11016535. DOI: 10.1038/s41598-024-59393-w.


The role of age in ocular toxoplasmosis: clinical signs of immunosenescence and inflammaging.

Eraghi A, Garweg J, Pleyer U Front Med (Lausanne). 2024; 11:1311145.

PMID: 38504919 PMC: 10950095. DOI: 10.3389/fmed.2024.1311145.


The epidemiology of patients with toxoplasmosis and its associated risk factors in Taiwan during the 2007-2020 period.

Yu C, Chen B, Chou Y, Hsieh C, Lin F PLoS One. 2023; 18(8):e0290769.

PMID: 37624831 PMC: 10456197. DOI: 10.1371/journal.pone.0290769.


Frequency of Toxocara Antibodies in Patients Clinically Suspected to Ocular Toxocariasis, Northeast of Iran.

Fata A, Hosseini S, Woo S, Zibaei M, Berenji F, Hosseini Farash B Iran J Parasitol. 2021; 16(2):305-311.

PMID: 34557246 PMC: 8418656. DOI: 10.18502/ijpa.v16i2.6312.

References
1.
Pathanapitoon K, Kunavisarut P, Ausayakhun S, Sirirungsi W, Rothova A . Uveitis in a tertiary ophthalmology centre in Thailand. Br J Ophthalmol. 2008; 92(4):474-8. DOI: 10.1136/bjo.2007.132175. View

2.
Balasundaram M, Andavar R, Palaniswamy M, Venkatapathy N . Outbreak of acquired ocular toxoplasmosis involving 248 patients. Arch Ophthalmol. 2010; 128(1):28-32. DOI: 10.1001/archophthalmol.2009.354. View

3.
Kovacevic-Pavicevic D, Radosavljevic A, Ilic A, Kovacevic I, Djurkovic-Djakovic O . Clinical pattern of ocular toxoplasmosis treated in a referral centre in Serbia. Eye (Lond). 2012; 26(5):723-8. PMC: 3351055. DOI: 10.1038/eye.2012.20. View

4.
Leblanc A, Bamberger J, Guillien F, Benoit A, Quillet P . [Acquired toxoplasmic chorioretinitis with a late onset]. Arch Fr Pediatr. 1985; 42(1):37-9. View

5.
Gilbert R, Stanford M . Is ocular toxoplasmosis caused by prenatal or postnatal infection?. Br J Ophthalmol. 2000; 84(2):224-6. PMC: 1723371. DOI: 10.1136/bjo.84.2.224. View